SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000902664-24-001539
Filing Date
2024-02-14
Accepted
2024-02-14 07:05:46
Documents
1

Document Format Files

Seq Description Document Type Size
1 ESSA PHARMA INC. p24-0731sc13g.htm SC 13G 72283
  Complete submission text file 0000902664-24-001539.txt   73957
Mailing Address 40 10TH AVENUE 7TH FLOOR NEW YORK NY 10014
Business Address 40 10TH AVENUE 7TH FLOOR NEW YORK NY 10014 646-597-6980
RTW INVESTMENTS, LP (Filed by) CIK: 0001493215 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (778) 331-0962
ESSA Pharma Inc. (Subject) CIK: 0001633932 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: SC 13G | Act: 34 | File No.: 005-88939 | Film No.: 24632212
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)